← Official tablesEvidence Matrix →

Open Source Medicine Foundation

Candidate pipeline board

Stages are advanced in the repository (python -m tables_workflow), not in this browser. Claim tiles are computed from Evidence Matrix nodes.

This is a read-only board. Advancing past evidence-gathering without meeting Claim-status gates requires a recorded override. A Table listing is a legal presumption, not a scientific verdict.

Kanban

hypothesis

None

petition filed

None

nprm published

None

public comment

None

final rule published

None

denied

None

Candidate detail + dockets

Myocarditis / pericarditis after COVID-19 mRNA vaccine petition drafted

Condition covid-myocarditis-pericarditis · definition v1 (under_review)

New myocarditis or pericarditis meeting CDC/Brighton clinical criteria, with symptom onset within 7 days after an mRNA COVID-19 vaccine dose, after competing causes are assessed. Definition version 1.

What’s blocking this

Claims (computed)

CodeClaimStatusMissing nodes
C1Coherent clinical object existssupported
C2Consistent temporal windowsupported
C3Epidemiologic excess riskcontested
C4Consistency / replicationcontested
C5Specificity (product / dose)supported
C6Biological mechanismsupported

Bradford Hill coverage

5 of 9 Hill criteria addressed: strength: addressed, consistency: not_addressed, specificity: addressed, temporality: addressed, biological_gradient: addressed, plausibility: addressed, coherence: not_addressed, experiment: not_addressed, analogy: not_addressed

Docket

status=not_yet_filed · RIN=— · docket=—

Petition drafted in-repo, not filed. Federal Register / regulations.gov stay empty until a RIN or docket number is entered.

Petition: data/tables_workflow/petitions/cand-covid-myocarditis.md · onset locked=True

Links: pipeline board

Evidence Matrix framework →

Small-fiber neuropathy / POTS after COVID-19 vaccine (PACVS-related hypothesis) evidence gathering

Condition covid-sfn-pots · definition v1 (under_review)

New small-fiber neuropathy documented by distal-leg intraepidermal nerve-fiber density below the performing laboratory’s age/sex-adjusted reference, and/or a QSART abnormality, with or without postural orthostatic tachycardia meeting consensus POTS criteria, with symptom onset within 42 days after a COVID-19 vaccine dose, after diabetes, Sjögren disease, vitamin B12 deficiency, and current SARS-CoV-2 infection have been assessed. PACVS is not the case object. Definition version 1 — locked for screening, not a Table QAI.

What’s blocking this

Claims (computed)

CodeClaimStatusMissing nodes
C1Coherent clinical object existssupported
C2Consistent temporal windowsupported
C3Epidemiologic excess riskinsufficient dataB1, B3
C4Consistency / replicationinsufficient dataB5, B6
C5Specificity (product / dose)insufficient dataC1n, C2n
C6Biological mechanismsupported

Bradford Hill coverage

4 of 9 Hill criteria addressed: strength: addressed, consistency: not_addressed, specificity: addressed, temporality: addressed, biological_gradient: not_addressed, plausibility: addressed, coherence: not_addressed, experiment: not_addressed, analogy: not_addressed

Docket

status=not_yet_filed · RIN=— · docket=—

Evidence-gathering. No docket. C3/C4/C5 remain insufficient_data after dual search (no SCCS, no VSD SFN/POTS RCA, no independent replication or meta-analysis of excess risk).

Petition: data/tables_workflow/petitions/cand-covid-sfn.md · onset locked=False

Links: pipeline board

Evidence Matrix framework →

eCFR watch

Federal Register watch

No Federal Register watch yet. Run python -m tables_workflow sync.

Sync: python -m tables_workflow sync · Petition draft: python -m tables_workflow petition cand-covid-myocarditis · Advance: python -m tables_workflow advance CANDIDATE STAGE --actor NAME --reason TEXT [--override]

Part of the Open Source Medicine Foundation Network

Open Source Medicine Foundation

Home of the OSMF network — open-source pharmacovigilance tools and evidence-based medicine resources.

Research Tracker

Track peer-reviewed literature on vaccine safety, pharmacovigilance, and post-market surveillance.

Evidence Desk

Soft launch — provisional claim grades; not medical advice. Does not contain vaccine lot or VAERS data.

SpikeProtein.site

Comprehensive resource on spike protein biology, biodistribution, and clinical implications.

VitalScan4PACVS

Decentralized trial for PACVS (post-acute COVID-19 vaccination syndrome).

PACVS Research Summit

Annual summit convening researchers and clinicians studying post-acute COVID-19 vaccination syndrome.